-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
- SAB Biotherapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $0.000.
- SAB Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $0.000.
- SAB Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
- SAB Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $25.6K.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)